Feng‐Bin Lu
Impact in
- Hepatology top 5%
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- Liver Disease Diagnosis and Treatment 6
-
- Liver Diseases and Immunity 3
- Co-authors
- Lanman Xu (7 shared papers)En-De Hu (7 shared papers)Ming‐Hua Zheng (6 shared papers)Jinlu Wu (6 shared papers)Da‐Zhi Chen (6 shared papers)Yongping Chen (6 shared papers)Yong‐Ping Chen (2 shared papers)Xiaoya Jin (4 shared papers)
In The Last Decade
Feng‐Bin Lu
11 papers receiving 694 citations
Peers
Comparison fields: 5 of 78
- Hepatology 129
- Cancer Research 138
- Epidemiology 285
- Endocrinology, Diabetes and Metabolism 96
- Genetics 42
Countries citing papers authored by Feng‐Bin Lu
This map shows the geographic impact of Feng‐Bin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Bin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Bin Lu more than expected).
Fields of papers citing papers by Feng‐Bin Lu
This network shows the impact of papers produced by Feng‐Bin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Bin Lu. The network helps show where Feng‐Bin Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng‐Bin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 195 | |
| 2 | 2018 | 111 | |
| 3 | 2020 | 82 | |
| 4 | 2018 | 78 | |
| 5 | 2018 | 77 | |
| 6 | 2019 | 62 | |
| 7 | 2017 | 32 | |
| 8 | 2018 | 22 | |
| 9 | 2020 | 19 | |
| 10 | [Effect of lycopene on oxidative stress and behavioral deficits in rotenone induced model of Parkinson's disease]. | 2013 | 18 |
| 11 | 2018 | 6 | |
| 12 | 2025 | 0 |
About Feng‐Bin Lu
Feng‐Bin Lu is a scholar working on Epidemiology, Hepatology, Molecular Biology, Pharmacology and Pathology and Forensic Medicine, having authored 12 papers that have together received 702 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Liver Diseases and Immunity (3 papers), Extracellular vesicles in disease (2 papers), Systemic Lupus Erythematosus Research (1 paper), Alcohol Consumption and Health Effects (1 paper), Coffee research and impacts (1 paper), Berberine and alkaloids research (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Hepatology (129 citations), Cancer Research (138 citations), Epidemiology (285 citations), Endocrinology, Diabetes and Metabolism (96 citations) and Genetics (42 citations). Feng‐Bin Lu has collaborated with scholars based in China, Canada and Italy. Frequent co-authors include Lanman Xu, En-De Hu, Ming‐Hua Zheng, Jinlu Wu, Da‐Zhi Chen, Yongping Chen, Yong‐Ping Chen, Xiaoya Jin, Zhuo Lin and Yuewen Gong. Their work appears in journals such as Molecular Immunology, Cellular Immunology, BMC Medical Genomics, Journal of Gastroenterology and Hepatology and Clinical Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.